Stock Taper
A U.S.-based company transitioning from ophthalmic drug delivery to becoming the first Nasdaq-listed firm with a cryptocurrency treasury in HYPE tokens, operating a validator, engaging in DeFi staking, and developing Optejet UFD™ for eye care.

Hyperion DeFi offers institutional clients access to staked HYPE tokens for reduced trading fees on Hyperliquid, earning income from the resulting savings through its proprietary on-chain service.
Overall rating: B+
| PEER | PRICE | |
|---|---|---|
VRCA | $5.69 | COMPARE |
ECOR | $9.63 | COMPARE |
MYO | $1.60 | COMPARE |
PIII | $9.22 | COMPARE |
NMTC | $1.77 | COMPARE |
JSPR | $0.70 | COMPARE |
MODD | $3.46 | COMPARE |
BTAI | $0.18 | COMPARE |